Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy.
King's College, London, UK.
Head Neck. 2020 Jul;42(7):1560-1569. doi: 10.1002/hed.26269. Epub 2020 May 21.
Objective data on chemosensitive disorders during COVID-19 are lacking in the Literature.
Multicenter cohort study that involved four Italian hospitals. Three hundred and forty-five COVID-19 patients underwent objective chemosensitive evaluation.
Chemosensitive disorders self-reported by 256 patients (74.2%) but the 30.1% of the 89 patients who did not report dysfunctions proved objectively hyposmic. Twenty-five percentage of patients were seen serious long-lasting complaints. All asymptomatic patients had a slight lowering of the olfactory threshold. No significant correlations were found between the presence and severity of chemosensitive disorders and the severity of the clinical course. On the contrary, there is a significant correlation between the duration of the olfactory and gustatory symptoms and the development of severe COVID-19.
Patients under-report the frequency of chemosensitive disorders. Contrary to recent reports, such objective testing refutes the proposal that the presence of olfactory and gustatory dysfunction may predict a milder course, but instead suggests that those with more severe disease neglect such symptoms in the setting of severe respiratory disease.
文献中缺乏关于 COVID-19 期间化学敏感性障碍的客观数据。
涉及四家意大利医院的多中心队列研究。345 名 COVID-19 患者接受了客观的化学敏感性评估。
256 名患者(74.2%)自述存在化学敏感性障碍,但有 89 名未报告功能障碍的患者中有 30.1%被证实嗅觉减退。25%的患者出现严重的长期投诉。所有无症状患者的嗅觉阈值略有降低。化学敏感性障碍的存在和严重程度与临床病程的严重程度之间没有发现显著相关性。相反,嗅觉和味觉症状的持续时间与严重 COVID-19 的发展之间存在显著相关性。
患者对化学敏感性障碍的频率报告不足。与最近的报告相反,这种客观测试反驳了嗅觉和味觉功能障碍的存在可能预示着较轻的病程的观点,而是表明那些病情较重的患者在严重呼吸道疾病的情况下忽视了这些症状。